BioCentury
ARTICLE | Clinical News

Daptacel diphtheria and tetanus toxoids and acellular pertussis regulatory update

May 20, 2002 7:00 AM UTC

The FDA granted marketing approval to AVE's Aventis Pasteur unit (Swiftwater, Penn.) for its DTaP vaccine to immunize children against diptheria, tetanus and pertussis. ...